Literature DB >> 6164804

Tolonium (toluidine blue) rinse--a screening method for recognition of squamous carcinoma. Continuing study of oral cancer IV.

A Mashberg.   

Abstract

Tolonium chloride (toluidine blue) application is useful for identifying malignant changes in squamous mucosa. However, early asymptomatic mucosal changes may remain undetected by tolonium application. A study was carried out to determine the feasibility of using a tolonium mouth rinse as a routine procedure after thorough clinical examination, to discover undetected cancers. A proved, effective tolonium application method was compared with a rinse sequence. One hundred five asymptomatic oral lesions (51 carcinomas and 54 nonmalignant lesions) that persisted for ten to 14 days were evaluated with application and rinse modalities and biopsies. There were 2% false-negatives (1/51) with the application as opposed to 5.9% (3/51) with the rinse and 9.3% false-positives (5/54) with the application as compared to 7.4% (4/54) with the rinse. Four inapparent, second primary cancers, unobserved for application, were delineated by the rinse (three oral, one pharyngeal). Tolonium blue rinse may be used to detect unobserved, asymptomatic oral mucosal cancers after clinical examination. After a positive rinse stain, a subsequent positive application stain ten to 14 days later mandates a biopsy of the lesion.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6164804

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  7 in total

1.  Utility of toluidine blue test in accessing and detecting intra-oral malignancies.

Authors:  Deepti Singh; R K Shukla
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2014-08-02

2.  Effect of cell-photosensitizer binding and cell density on microbial photoinactivation.

Authors:  Tatiana N Demidova; Michael R Hamblin
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

3.  Relevance of tumor angiogenesis patterns as a diagnostic value and prognostic indicator in oral precancer and cancer.

Authors:  Devi Charan Shetty; Puneet Ahuja; D K Taneja; Ajit Singh Rathore; Shivjot Chhina; Upasana Sethi Ahuja; Kiran Kumar; Anshuman Ahuja; Priyanka Rastogi
Journal:  Vasc Health Risk Manag       Date:  2011-01-27

Review 4.  Adjunctive aids for the detection of oral premalignancy.

Authors:  D Charanya; L P Raghupathy; Amjad Fazeela Farzana; R Murugan; R Krishnaraj; G Kalarani
Journal:  J Pharm Bioallied Sci       Date:  2016-10

5.  Lugol Chromoscopy in the Follow-up of Head and Neck Carcinoma.

Authors:  Cesar Augusto Simões; Marcelo Doria Durazzo; Flávia Caló de Aquino Xavier; Marina Helena Cury Gallottini; Sílvia Vanessa Lourenço; Décio Dos Santos Pinto Júnior; Natália Martins Magacho de Andrade; Aline Paterno Miazaki; Rogério Aparecido Dedivitis; Cláudio Roberto Cernea
Journal:  Ann Maxillofac Surg       Date:  2017 Jul-Dec

6.  Monocarboxylate Transporter 4 (MCT4) Knockout Mice Have Attenuated 4NQO Induced Carcinogenesis; A Role for MCT4 in Driving Oral Squamous Cell Cancer.

Authors:  Sara Bisetto; Diana Whitaker-Menezes; Nicole A Wilski; Madalina Tuluc; Joseph Curry; Tingting Zhan; Christopher M Snyder; Ubaldo E Martinez-Outschoorn; Nancy J Philp
Journal:  Front Oncol       Date:  2018-08-28       Impact factor: 6.244

7.  Application of in vivo stain of methylene blue as a diagnostic aid in the early detection and screening of oral cancerous and precancerous lesions.

Authors:  Manas Gupta; Kriti Shrivastava; Vikalp Raghuvanshi; Sakshi Ojha; Ankita Gupta; S Sasidhar
Journal:  J Oral Maxillofac Pathol       Date:  2019 May-Aug
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.